A pivotal life sciences investment for London’s Canary Wharf
Canary Wharf Group and AXA IM Alts' Kadans Science Partner will be investing £500m in Europe's largest commercial lab building.
Canary Wharf Group and AXA IM Alts' Kadans Science Partner will be investing £500m in Europe's largest commercial lab building.
Copyright PEI Media
Not for publication, email or dissemination
